Gavin P. Dunn

30.3k citations

136 papers · 16.4k indexed · 7 hit papers · h-index 45

Impact in

Immunology top 0.1%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Immune cells in cancer
- T-cell and B-cell Immunology
- interferon and immune responses
Oncology top 0.1%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research

Papers in

Genetics 50
- Glioma Diagnosis and Treatment 50
Oncology 62
- Cancer Immunotherapy and Biomarkers 41
- CAR-T cell therapy research 12

Co-authors: Robert D. Schreiber Lloyd J. Old Allen T. Bruce Hiroaki Ikeda Catherine Koebel Mark J. Smyth Ravindra Uppaluri J. Michael White
Journals: Neuro-Oncology (10 papers)Journal of Clinical Oncology (9 papers)Neurosurgical FOCUS (7 papers)Clinical Cancer Research (6 papers)Neuro-Oncology Advances (5 papers)
Partner nations: United States Australia United Kingdom

In The Last Decade

Gavin P. Dunn

127 papers receiving 16.1k citations

Hit Papers

7 papers align trajectories log scale

Emerging insights into the molecular and cellular basis of glioblastoma 2012 · 425 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2012 Genes & Development
2011 The Journal of Experimental Medicine
2006 Nature reviews. Immunology
2006 Advances in immunology
2004 Annual Review of Immunology
2004 Immunity
2002 Nature Immunology

Peers

Countries citing papers authored by Gavin P. Dunn

Since Specialization

Citations

This map shows the geographic impact of Gavin P. Dunn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gavin P. Dunn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gavin P. Dunn more than expected).

Fields of papers citing papers by Gavin P. Dunn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gavin P. Dunn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gavin P. Dunn. The network helps show where Gavin P. Dunn may publish in the future.

Co-authors

The 25 scholars most cited alongside Gavin P. Dunn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Gavin P. Dunn Line = papers co-authored together Gavin P. Dunn links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	A Phase 1/2 Study of Disulfiram and Copper With Concurrent Radiation Therapy and Temozolomide for Patients With Newly Diagnosed Glioblastoma International Journal of Radiation OncologyBiologyPhysics ·Jiayi Huang, Jian Campian, T.A. DeWees, Zdeněk Škrott, Martin Mistrík, Tanner M. Johanns, George Ansstas, Omar H. Butt, Eric C. Leuthardt, Gavin P. Dunn, Gregory J. Zipfel, Joshua W. Osbun, Christopher Abraham, Shahed N. Badiyan, Katherine E. Schwetye, J. Gregory Cairncross, Joshua B. Rubin, Albert H. Kim, Milan G. Chheda	2024	11
2	GSTM1 null genotype underpins recurrence of NF2 meningiomas Frontiers in Oncology ·Anthony C. Johnson, Erdyni N. Tsitsikov, Silvia Rothen, Jeffrey Zuccato, Andrew M. Bauer, Christopher S. Graffeo, Rūta Stankuvienė, Maria Gabriella Fernandes de Oliveira Souza, Yufeng Liu, Gavin P. Dunn, Alla V. Tsytsykova, Pamela S. Jones, Ian F. Dunn	2024	1
3	A Low Subfrontal Dural Opening for Operative Management of Anterior Skull Base Lesions Journal of Neurological Surgery Part B Skull Base ·Mandi du Plessis, Gavin P. Dunn, Gregory J. Zipfel, Ralph G. Dacey, Michael R. Chicoine	2022	1
4	The Conventional Dendritic Cell 1 Subset Primes CD8+ T Cells and Traffics Tumor Antigen to Drive Antitumor Immunity in the Brain Cancer Immunology Research ·Jay A. Bowman-Kirigin, Rupen Desai, Brian T. Saunders, Anthony Z. Wang, Maximilian O. Schaettler, Connor J. Liu, Alexandra J. Livingstone, Dale K. Kobayashi, Vivek Durai, Nicole M. Kretzer, Gregory J. Zipfel, Eric C. Leuthardt, Joshua W. Osbun, Michael R. Chicoine, Albert H. Kim, Kenneth M. Murphy, Tanner M. Johanns, Bernd H. Zinselmeyer, Gavin P. Dunn	2022	24
5	Neoadjuvant stereotactic radiosurgery for brain metastases: a new paradigm Neurosurgical FOCUS ·Xin-Huang Chen, Barbara Lundblad, Jiayi Huang, Christopher Abraham, Joshua L. Dowling, Eric C. Leuthardt, Gavin P. Dunn, Albert H. Kim, Ralph G. Dacey, Gregory J. Zipfel, John A. Evans, Beatriz de Elguezábal, Michael R. Chicoine	2022	7
6	Glioblastoma Clinical Trials: Current Landscape and Opportunities for Improvement Clinical Cancer Research ·Stephen Bagley, Shawn Kothari, Rifaquat Rahman, Eudocia Q. Lee, Gavin P. Dunn, Evanthia Galanis, Susan M. Chang, Burt Nabors, Manmeet S. Ahluwalia, Roger Stupp, Minesh P. Mehta, David A. Reardon, Stuart A. Grossman, Erik P. Sulman, John H. Sampson, Simon Khagi, Michael Weller, Timothy F. Cloughesy, Patrick Y. Wen, Mustafa Khasraw	2021	104
7	Yap1 Mediates Trametinib Resistance in Head and Neck Squamous Cell Carcinomas Clinical Cancer Research ·Tenny Mudianto, Katie M. Campbell, Jason A. Webb, Paul Zolkind, Zachary L. Skidmore, Rachel Riley, Erica K. Barnell, Valerie Patten, Tusar Giri, Gavin P. Dunn, Douglas R. Adkins, Malachi Griffith, Ann Marie Egloff, Obi L. Griffith, Ravindra Uppaluri	2021	18
8	Salvage therapies for radiation-relapsed isocitrate dehydrogenase-mutant astrocytoma and 1p/19q codeleted oligodendroglioma Neuro-Oncology Advances ·Si‐Rui Ma, Soumon Rudra, Jian Campian, Milan G. Chheda, Tanner M. Johanns, George Ansstas, Christopher Abraham, Michael R. Chicoine, Eric C. Leuthardt, Joshua L. Dowling, Gavin P. Dunn, Albert H. Kim, Jiayi Huang	2021	1
9	Characterization of the Genomic and Immunologic Diversity of Malignant Brain Tumors through Multisector Analysis Cancer Discovery ·Maximilian O. Schaettler, Megan M. Richters, Anthony Z. Wang, Zachary L. Skidmore, Bryan Fisk, Katherine E. Miller, Tammi L. Vickery, Albert H. Kim, Michael R. Chicoine, Joshua W. Osbun, Eric C. Leuthardt, Joshua L. Dowling, Gregory J. Zipfel, Ralph G. Dacey, Hsiang‐Chih Lu, Tanner M. Johanns, Obi L. Griffith, Elaine R. Mardis, Malachi Griffith, Gavin P. Dunn	2021	38
10	Consensus recommendations for a standardized brain tumor imaging protocol for clinical trials in brain metastases Neuro-Oncology ·Timothy J. Kaufmann, Marion Smits, Jerrold L. Boxerman, Raymond Y. Huang, Daniel P. Barboriak, Michael Weller, Caroline Chung, Christina Tsien, Paul D. Brown, Lalitha Shankar, Evanthia Galanis, Elizabeth R. Gerstner, Martin J. van den Bent, Terry C. Burns, Ian F. Parney, Gavin P. Dunn, Priscilla K. Brastianos, Nancy U. Lin, Patrick Y. Wen, Benjamin M. Ellingson	2020	150
11	A deep learning approach to automate refinement of somatic variant calling from cancer sequencing data Nature Genetics ·Benjamin J. Ainscough, Erica K. Barnell, Peter Ronning, Katie M. Campbell, Alex H. Wagner, Todd A. Fehniger, Gavin P. Dunn, Ravindra Uppaluri, Ramaswamy Govindan, Thomas E. Rohan, Malachi Griffith, Elaine R. Mardis, S. Joshua Swamidass, Obi L. Griffith	2018	50
12	Immunogenomics of Hypermutated Glioblastoma: A Patient with Germline POLE Deficiency Treated with Checkpoint Blockade Immunotherapy Cancer Discovery ·Tanner M. Johanns, Christopher A. Miller, Ian G. Dorward, Christina Tsien, Edward F. Chang, Arie Perry, Ravindra Uppaluri, Cole Ferguson, Robert E. Schmidt, Sonika Dahiya, George Ansstas, Elaine R. Mardis, Gavin P. Dunn	2016	209
13	Endogenous Neoantigen-Specific CD8 T Cells Identified in Two Glioblastoma Models Using a Cancer Immunogenomics Approach Cancer Immunology Research ·Tanner M. Johanns, Jeffrey P. Ward, Christopher A. Miller, J.-M. Bartoli, Dale K. Kobayashi, Diane E. Bender, Yujie Fu, Anton Alexandrov, Elaine R. Mardis, Maxim N. Artyomov, Robert D. Schreiber, Gavin P. Dunn	2016	80
14	Clinical and Dosimetric Predictors of Acute Severe Lymphopenia During Radiation Therapy and Concurrent Temozolomide for High-Grade Glioma International Journal of Radiation OncologyBiologyPhysics ·Jiayi Huang, T.A. DeWees, Shahed N. Badiyan, Christina K. Speirs, D. Mullen, S. Fergus, David Tran, S. Lee, Jian Campian, Michael R. Chicoine, Albert H. Kim, Gavin P. Dunn, Joseph R. Simpson, Clifford G. Robinson	2015	82
15	A Surprising Cross-Species Conservation in the Genomic Landscape of Mouse and Human Oral Cancer Identifies a Transcriptional Signature Predicting Metastatic Disease Clinical Cancer Research ·Michael D. Onken, Ashley E. Winkler, Krishna-Latha Kanchi, Marta Pedrerol i Mas, Jonathan H. Law, Charles G. Rickert, Dorina Kallogjeri, Nancy P. Judd, Gavin P. Dunn, Jay F. Piccirillo, James S. Lewis, Elaine R. Mardis, Ravindra Uppaluri	2014	83
16	The Tyrosine Kinase Adaptor Protein FRS2 Is Oncogenic and Amplified in High-Grade Serous Ovarian Cancer Molecular Cancer Research ·Leo Y. Luo, Eejung Kim, Hiu Wing Cheung, Barbara A. Weir, Gavin P. Dunn, Rhine R. Shen, William C. Hahn	2014	29
17	Spontaneous Resorption of a Penetrating Orbital Bone Fracture Fragment Ophthalmic Plastic and Reconstructive Surgery ·Ashley A. Campbell, Mary E. Cunnane, Gavin P. Dunn, Angela Lorenzo, Daniel R. Lefebvre	2014	1
18	ERK1/2 Regulation of CD44 Modulates Oral Cancer Aggressiveness Cancer Research ·Nancy P. Judd, Ashley E. Winkler, Oihana Murillo, Joshua J. Brotman, Jonathan H. Law, James S. Lewis, Gavin P. Dunn, Jack D. Bui, John B. Sunwoo, Ravindra Uppaluri	2011	172
19	Type I interferon is selectively required by dendritic cells for immune rejection of tumors The Journal of Experimental Medicine ·Mark S. Diamond, Michelle Kinder, Hirokazu Matsushita, Mona Mashayekhi, Gavin P. Dunn, 卢柱华, Hsiaoju Lee, Cora D. Arthur, J. Michael White, Ulrich Kalinke, Kenneth M. Murphy, Robert D. Schreiber Hit paper breakdown →	2011	864
20	Blocking Monoclonal Antibodies Specific for Mouse IFN- α / β Receptor Subunit 1 (IFNAR-1) from Mice Immunized by In Vivo Hydrodynamic Transfection Journal of Interferon & Cytokine Research ·Kathleen C. F. Sheehan, Koon Siew Lai, Gavin P. Dunn, Allen T. Bruce, Mark S. Diamond, Hüsna ÖZVEREN, A. A. Pavlusik, Javier A. Carrero, J. Michael White, Paul J. Hertzog, Robert D. Schreiber	2006	206

About Gavin P. Dunn

Gavin P. Dunn is a scholar working on Genetics, Oncology, Immunology, Cancer Research and Neurology, having authored 136 papers that have together received 16.4k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (50 papers), Cancer Immunotherapy and Biomarkers (41 papers), Immunotherapy and Immune Responses (32 papers), Cancer Genomics and Diagnostics (15 papers), CAR-T cell therapy research (12 papers), Brain Metastases and Treatment (11 papers), Immune Cell Function and Interaction (11 papers) and Meningioma and schwannoma management (11 papers). The work is most often cited by research in Immunology (8.9k citations), Oncology (8.4k citations), Genetics (2.0k citations), Cancer Research (1.9k citations) and Modeling and Simulation (294 citations). Gavin P. Dunn has collaborated with scholars based in United States, Australia and United Kingdom. Frequent co-authors include Robert D. Schreiber, Lloyd J. Old, Allen T. Bruce, Hiroaki Ikeda, Catherine Koebel, Mark J. Smyth, Ravindra Uppaluri, J. Michael White, Mark S. Diamond and Cora D. Arthur. Their work appears in journals such as Neuro-Oncology, Journal of Clinical Oncology, Neurosurgical FOCUS, Clinical Cancer Research and Neuro-Oncology Advances.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact